Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PDMR Announcement

27th May 2026 16:26

RNS Number : 9370F
Melrose Industries PLC
27 May 2026
 

27 May 2026

Melrose Industries PLC (the "Company")

Notification and Public Disclosure of Transactions of Persons Discharging Managerial Responsibilities

The Company announces that it has been informed that Gillian Elcock, Non-executive Director, purchased 1,987 Ordinary Shares of £0.001 in the Company (the "Shares") on 22 May 2026 at a price of 503 pence per Share. In total, Ms Elcock holds an interest of 5,667 Ordinary Shares in the Company.

 

Enquiries:

Investor Relations: Mat Wootton

 

+44 (0) 7483 961 233, [email protected]

 

Media: Simon Sporborg, Tom Pigott

 

+44 (0) 207 404 5959, [email protected]

 

Notification of Transactions of Persons Discharging Managerial Responsibility in accordance with Article 19(1) of MAR

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name of natural person

Gillian Elcock

2.

Reason for the notification

a)

Position / status

Non-executive Director

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Full name of the entity

Melrose Industries PLC

b)

Legal Entity Identifier code

213800RGNXXZY2M7TR85

4.

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.001 each

b)

Identification Code

GB00BNGDN821

c)

Nature of the transaction

Acquisition of ordinary shares of £0.001 pence each

d)

Currency

GBP - British Pound

e)

Price(s) and volume(s)

 

Price

Volume

GBP 5.03

1,987

f)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

1,987

 

GBP 9,994.61

g)

Date of the transaction

 22 May 2026

h)

Place of the transaction

London Stock Exchange

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZDLFLQELEBBV

Related Shares:

Melrose
FTSE 100 Latest
Value10,421.39
Change-83.62